CTCs-oriented adjuvant personalized cytostatic therapy non-metastatic breast cancer patients: continuous non-randomized prospective study and prospective randomized controlled study

THE AIM: To conduct a prospective randomized controlled study of the optimization of adjuvant therapy in patients with non-metastatic breast cancer, taking into account the presence of circulating tumor cells (CTCs) with an assessment of tumor-specific OS and DFS. MATERIALS: Stage 1 Continuous non-r...

Descripción completa

Detalles Bibliográficos
Autor principal: Shliakhtunou, Ya A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990849/
https://www.ncbi.nlm.nih.gov/pubmed/33389399
http://dx.doi.org/10.1007/s10549-020-06036-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990849/
https://www.ncbi.nlm.nih.gov/pubmed/33389399
http://dx.doi.org/10.1007/s10549-020-06036-z

Ejemplares similares